FACT
FACT II Acquisition Corp
There isn't enough reported data to score FACT yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
FACT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| N/A | |
| N/A |
FACT's profitability is currently stable. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like FACT.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
FACT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 49x | $8.73 | -19% |
| Fair | 53x | $9.53 | -12% |
| Current | 60x | $10.79 | — |
| Expensive | 96x | $17.29 | +60% |
Historical ranges are pointers, not guarantees.
FACT has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
FACT Forward outlook
There aren't enough analyst estimates for FACT to show an outlook.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
FACT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.18 | -10% |
| Q2 2026 | $0.20 | +82% |
| Q1 2026 | $0.22 | +$0.82 |
| Q4 2025 | $0.22 | +$1.26 |
| Q3 2025 | $0.20 | +$3.75 |
| Q2 2025 | $0.11 | +$8.84 |
| Q1 2023 | $0.11 | +57% |
| Q4 2022 | $0.13 | +8.3% |
FACT earned $0.18 per share over the past year, down 10% from the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over FACT on earnings, with more consistent year-over-year improvement.
FACT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $94.2M | +49% |
FACT's revenue has slid since its 2024 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | -1% | +58 points |
| Q2 2024 | -211% | N/A |
| Q1 2024 | -75% | N/A |
| Q4 2023 | -59% | N/A |
| Q3 2023 | -45% | N/A |
FACT's operating margin was −1% last quarter, up 44 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over FACT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
FACT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$97.6K | -$16.7K |
| Q2 2026 | -$242.4K | -$108.9K |
| Q1 2026 | -$131.9K | +$94K |
| Q4 2025 | -$462.8K | -$208.7K |
| Q3 2025 | -$80.8K | -$29.8K |
| Q2 2025 | -$133.6K | -$133.6K |
| Q1 2025 | -$225.9K | +$4.7M |
| Q4 2024 | -$254.1K | -100% |
FACT's free cash flow was −$934,734 over the past year, against −$694,402 the year before. Free cash flow isn't a meaningful measure for financial services companies like FACT.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM has the edge over FACT on cash flow, with more consistent year-over-year improvement.
FACT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +32% | +5.8M shares |
| 1 year | +32% | +5.8M shares |
| 3 years | -39% | -15.5M shares |
| 5 years | -42% | -17.7M shares |
FACT has 24M diluted shares, up 32% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q2 2024 | — |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over FACT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
FACT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -1.2x | Net Cash |
| Q1 2023 | 0.6x | Very low |
| Q4 2022 | 0.2x | Very low |
| Q3 2022 | 0.1x | Very low |
FACT has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like FACT.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
FACT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 76.0 | Overbought |
| Stochastic | 94.2 | Overbought |
FACT's weekly RSI is 76 (overbought) and its Stochastic is 94 (overbought).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
FACT PE vs Financial Services Sector
| Metric | FACT | Sector median | Relative |
|---|---|---|---|
| PE | 60x | 13x | 360% above |
| PE % | 80 | 22 | 58 pts above |
FACT is trading at 60x earnings, a 360% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over FACT on valuation relative to its sector.
FACT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.8 | 0.3% above |
| 20 week MA | $10.7 | 0.7% above |
| 50 week MA | $10.6 | 1.8% above |
| 100 week MA | $10.4 | 3.9% above |
FACT has stronger trend alignment. FACT is above 4 of 4 weekly averages versus JPM above 4 of 5.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
FACT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $9.88 | $9.88 | 0% |
| 2025 | $9.88 | $10.4 | +5.2% |
| 2026 YTD | $10.4 | $10.8 | +3.8% |
FACT has finished lower in one of the last two years. It's up 3.8% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over FACT on returns for 2026, with the stronger performance.